Insmed
INSM
INSM
176 hedge funds and large institutions have $2.35B invested in Insmed in 2019 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 53 increasing their positions, 56 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
176
Holders Change
+19
Holders Change %
+12.1%
% of All Funds
3.48%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.12%
New
38
Increased
53
Reduced
56
Closed
19
Calls
$16.4M
Puts
$20M
Net Calls
-$3.57M
Net Calls Change
+$3.94M
Top Buyers
| 1 |
1
Millennium Management
New York
|
$19.7M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$320M |
| 3 |
3
D.E. Shaw & Co
New York
|
$71.4M |
| 4 |
4
Ameriprise
Minneapolis,
Minnesota
|
$54.6M |
| 5 |
5
Barclays
London,
United Kingdom
|
$11.1M |
Top Sellers
| 1 |
CS
1
Credit Suisse
Zurich,
Switzerland
|
$1.83M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$82.2M |
| 3 |
3
Wellington Management Group
Boston,
Massachusetts
|
$1.01M |
| 4 |
O
4
OrbiMed
New York
|
$1.41M |
| 5 |
5
Point72 Asset Management
Stamford,
Connecticut
|
$5.75M |
